pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 28·1 min read
save

U.S. policy bars Ebola patients from entering country, plans overseas evacuation

May 28, 2026·read at STAT ↗RegulatoryNegative

U.S. health officials announced that any American who contracts Ebola will not be taken to the United States for care. Instead, patients will be moved to undisclosed locations in Europe for treatment or quarantine.

The policy contrasts with the 2014 response when a physician who fell ill in West Africa was treated at a New York hospital and survived. Officials said the new approach reflects heightened concerns about importing the virus.

Experts warn that the change could create additional risks for infected travelers and may discourage medical volunteers from working in the affected regions of the Democratic Republic of Congo and Uganda.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress”

read at STAT ↗
536 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLYOVERSEAS
drugs
Undisclosed
topics
Oncology3Vaccine2IBD (Crohn's + UC)Vaccines

related stories

  • 4d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Soufflé cooks up $135M; Matchpoint makes $150MFierce Biotech
  • Sep 286 immunology targets to sustain a mammoth I&I marketBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Oct 75 biggest venture capital raises of Q3 2026BioSpace